The effects of the therapy in a small group of patients were long-lasting, researchers say, adding to evidence that the approach works for treatment-resistant depression.
Direct-to-consumer neurotechnologies using EEG or tDCS are becoming increasingly popular, but some scientists are concerned about the lack of evidence for efficacy.
Receptors that bind the active ingredient in marijuana may be novel therapeutic targets in autoimmune disease, but contested evidence for their presence on neurons could hamper drug development